This week I thought I’d lay out the rationale behind our annual conference, now in its sixth year, which now covers private health care across Europe and all Emerging markets....
Given the size of the opportunity it is striking how little money is being invested by large financial institutions, private equity houses and big quoted groups in Emerging Markets. Why? And what is the way forward?
Pihlajalinna, the Finnish healthcare and social services outfit, which recently IPOed with a market capitalisation of €255m, has struck a third joint venture with Finnish municipalities to outsource health and social services. Finland is likely to open up even more to the private sector under the current government.
Seven Finnish physiotherapy companies, backed by private equity firm Vaaka Partners, have merged to form Finland’s largest chain of physiotherapy. Pasi Syrjä, director of business development at the new company tells Healthcare Europa about the group’s ambitions.
Brazil’s healthcare system is fragmented, inefficient and underfunded. Still, this is Latin America’s largest private healthcare market and is consolidating fast. What are the characteristics of the Brazilian healthcare system? Here we look at the structure of the market and segments such as health insurance, acute care and diagnostics.
Medicover, the Pan-East European subscription and lab provider, has its eyes on buying one of the two big Romanian healthcare chains, which are now for sale. We also get feedback on its new lab operation in Moscow and assess other bidders.
Dutch private equity specialist Gilde Healthcare has closed a new €100m healthcare services fund in just three months. We speak to Jasper van Gorp, managing partner at Gilde, about the fund.
The minority shareholder in AGEL, the big Czech and Slovak hospital group wants to sell or buy the entire group. But AGEL sources say majority owner Tomas Chrenek won't sell and is looking at opportunities internationally.
We talk to academics and policymakers about TTIP's potential impact on public sector healthcare provision in Europe. Fear, uncertainty and doubt surround the discussions between the European Union and the United States on the Transatlantic Trade & Investment Partnership (TTIP) and its possible impact on public healthcare services.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
